医学
彭布罗利珠单抗
佐剂
肾细胞癌
肾切除术
辅助治疗
肿瘤科
内科学
癌
泌尿科
免疫疗法
肾
癌症
作者
Toni K. Choueiri,Piotr Tomczak,Se Hoon Park,Balaji Venugopal,Thomas Ferguson,Yen‐Hwa Chang,Jaroslav Hájek,Stefan N. Symeonides,Jae‐Lyun Lee,Naveed Sarwar,Antoine Thiery-Vuillemin,Marine Gross‐Goupil,Mauricio Mahave,Naomi B. Haas,Piotr Sawrycki,Howard Gurney,Christine Chevreau,Bohuslav Melichar,Evgeniy Kopyltsov,Ajjai Alva
标识
DOI：10.1056/nejmoa2106391
摘要
Pembrolizumab treatment led to a significant improvement in disease-free survival as compared with placebo after surgery among patients with kidney cancer who were at high risk for recurrence. (Funded by Merck Sharp and Dohme, a subsidiary of Merck; KEYNOTE-564 ClinicalTrials.gov number, NCT03142334.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
BowieHuang
ceeray23
无极微光
Criminology34
子车茗
niNe3YUE
Zx_1993
黑猫乾杯
freyaaaaa
Stella
优美紫槐
积极从蕾
ZOE
小琳
所所
VDC
淡淡的南风
tuanheqi
香蕉诗蕊
小药童
叶叶
小青椒
萧萧
pcr163
皖公网安备34019202002308
